This company runs a biopharmaceuticals business. Its primary focus is on gastrointestinal diseases. It currently sells three drugs in the US - Movantik, Talicia and Aemcolo.
This company runs a biopharmaceuticals business. Its primary focus is on gastrointestinal diseases. It currently sells three drugs in the US - Movantik, Talicia and Aemcolo.